{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:59:11Z","timestamp":1792241951248,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272298"],"award-info":[{"award-number":["82272298"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772062"],"award-info":[{"award-number":["81772062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bcp.2024.116574","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T17:15:44Z","timestamp":1728666944000},"page":"116574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"P1","title":["Ursodeoxycholic acid alleviates fat embolism syndrome-induced acute lung injury by inhibiting the p38 MAPK\/NF-\u03baB signalling pathway through FXR"],"prefix":"10.1016","volume":"230","author":[{"given":"Xudong","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinye","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcp.2024.116574_b0005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/CS20070011","article-title":"Clinical and pathological features of fat embolism with acute respiratory distress syndrome","volume":"113","author":"Kao","year":"2007","journal-title":"Clin Sci (lond)"},{"key":"10.1016\/j.bcp.2024.116574_b0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.wneu.2018.08.148","article-title":"Cerebral Fat Embolism as Complication of Facial Fat Graft: Retrospective Analysis of Clinical Characteristics","volume":"120","author":"Huo","year":"2018","journal-title":"Treatment, and Prognosis, World Neurosurg"},{"issue":"10","key":"10.1016\/j.bcp.2024.116574_b0015","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1164\/rccm.201001-0074UP","article-title":"Update on acute lung injury and critical care medicine 2009","volume":"181","author":"Matthay","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bcp.2024.116574_b0020","first-page":"241","article-title":"Fat embolism","volume":"66","author":"Peltier","year":"1969","journal-title":"A Current Concept, Clin Orthop Relat Res"},{"key":"10.1016\/j.bcp.2024.116574_b0025","doi-asserted-by":"crossref","unstructured":"L.F. Peltier, Fat embolism. A perspective, Clin Orthop Relat Res (232) (1988) 263-70.","DOI":"10.1097\/00003086-198807000-00033"},{"issue":"3","key":"10.1016\/j.bcp.2024.116574_b0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/CIRCULATIONAHA.114.010835","article-title":"Fat embolism syndrome","volume":"131","author":"Kosova","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bcp.2024.116574_b0035","first-page":"439","article-title":"Ursodeoxycholic acid in the treatment of cholestatic liver diseases","volume":"121","author":"Arrese","year":"1993","journal-title":"Rev Med Chil"},{"issue":"5","key":"10.1016\/j.bcp.2024.116574_b0040","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep.20897","article-title":"Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis","volume":"42","author":"Combes","year":"2005","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.bcp.2024.116574_b0045","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","article-title":"Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients","volume":"101","author":"ter Borg","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.bcp.2024.116574_b0050","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/gut.2006.109934","article-title":"Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones","volume":"56","author":"Guarino","year":"2007","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.bcp.2024.116574_b0055","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2024.116574_b0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.intimp.2018.11.005","article-title":"Obeticholic acid alleviate lipopolysaccharide-induced acute lung injury via its anti-inflammatory effects in mice","volume":"66","author":"Fei","year":"2019","journal-title":"Int Immunopharmacol"},{"issue":"20","key":"10.1016\/j.bcp.2024.116574_b0065","doi-asserted-by":"crossref","first-page":"33265","DOI":"10.18632\/oncotarget.16633","article-title":"Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bcp.2024.116574_b0070","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/jcp.29080","article-title":"Glycochenodeoxycholate promotes the metastasis of gallbladder cancer cells by inducing epithelial to mesenchymal transition via activation of SOCS3\/JAK2\/STAT3 signaling pathway","volume":"235","author":"Wang","year":"2020","journal-title":"J Cell Physiol"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116574_b0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-1119(02)00557-7","article-title":"Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters","volume":"290","author":"Huber","year":"2002","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.bcp.2024.116574_b0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.510300121","article-title":"Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis","volume":"30","author":"Yamazaki","year":"1999","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.bcp.2024.116574_b0085","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/all.12019","article-title":"Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor","volume":"67","author":"Willart","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.bcp.2024.116574_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174321","article-title":"Dioscin alleviates lung ischemia\/reperfusion injury by regulating FXR-mediated oxidative stress, apoptosis, and inflammation","volume":"908","author":"Dong","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"10.1016\/j.bcp.2024.116574_b0095","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1021\/jm0002127","article-title":"Identification of a chemical tool for the orphan nuclear receptor FXR","volume":"43","author":"Maloney","year":"2000","journal-title":"J Med Chem"},{"issue":"11","key":"10.1016\/j.bcp.2024.116574_b0100","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0960-894X(03)00281-6","article-title":"Binding mode of 6ECDCA, a potent bile acid agonist of the farnesoid X receptor (FXR)","volume":"13","author":"Costantino","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"10.1016\/j.bcp.2024.116574_b0105","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1097-2765(03)00112-6","article-title":"Structural basis for bile acid binding and activation of the nuclear receptor FXR","volume":"11","author":"Mi","year":"2003","journal-title":"Mol Cell"},{"issue":"17","key":"10.1016\/j.bcp.2024.116574_b0110","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/jm025529g","article-title":"6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity","volume":"45","author":"Pellicciari","year":"2002","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bcp.2024.116574_b0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-2275(20)38183-9","article-title":"7 beta-Dehydroxylation of ursodeoxycholic acid by whole cells and cell extracts of the intestinal anaerobic bacterium, Eubacterium species V.P.I. 12708","volume":"23","author":"White","year":"1982","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.bcp.2024.116574_b0120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","article-title":"Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'","volume":"35","author":"Lazaridis","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.bcp.2024.116574_b0125","doi-asserted-by":"crossref","unstructured":"K. Wang, M. Liao, N. Zhou, L. Bao, K. Ma, Z. Zheng, Y. Wang, C. Liu, W. Wang, J. Wang, S.J. Liu, H. Liu, Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids, Cell Rep 26(1) (2019) 222-235 e5.","DOI":"10.1016\/j.celrep.2018.12.028"},{"issue":"1","key":"10.1016\/j.bcp.2024.116574_b0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40168-022-01458-x","article-title":"Gut microbiota-derived ursodeoxycholic acid alleviates low birth weight-induced colonic inflammation by enhancing M2 macrophage polarization","volume":"11","author":"Pi","year":"2023","journal-title":"Microbiome"},{"issue":"7","key":"10.1016\/j.bcp.2024.116574_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071183","article-title":"The Effects of Aquaporin-1 in Pulmonary Edema Induced by Fat Embolism Syndrome","volume":"17","author":"Zhang","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.bcp.2024.116574_b0140","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00330-016-4512-2","article-title":"Detection of pulmonary fat embolism with dual-energy CT: an experimental study in rabbits","volume":"27","author":"Tang","year":"2017","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.bcp.2024.116574_b0145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1378\/chest.69.4.523","article-title":"The role of hypovolemic stress in the production of fat embolism in rabbits. 1. Morphologic alterations of the lungs","volume":"69","author":"Cotev","year":"1976","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.bcp.2024.116574_b0150","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.4049\/jimmunol.178.12.8127","article-title":"Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury","volume":"178","author":"Eckle","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2024.116574_b0155","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1038\/ncomms8796","article-title":"Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1","volume":"6","author":"Vettorazzi","year":"2015","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.bcp.2024.116574_b0160","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.cell.2006.06.043","article-title":"ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation","volume":"126","author":"Umeda","year":"2006","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bcp.2024.116574_b0165","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1158\/0008-5472.CAN-04-0265","article-title":"Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells","volume":"64","author":"Rabascio","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2024.116574_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110080","article-title":"Farnesoid X receptor protects against lipopolysaccharide-induced endometritis by inhibiting ferroptosis and inflammatory response","volume":"118","author":"Cao","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"10.1016\/j.bcp.2024.116574_b0175","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.bcp.2024.116574_b0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tcb.2008.10.001","article-title":"Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player","volume":"19","author":"Vestweber","year":"2009","journal-title":"Trends Cell Biol"},{"issue":"5","key":"10.1016\/j.bcp.2024.116574_b0185","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.bbadis.2014.12.016","article-title":"Prostacyclin post-treatment improves LPS-induced acute lung injury and endothelial barrier recovery via Rap1","volume":"1852","author":"Birukova","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.bcp.2024.116574_b0190","doi-asserted-by":"crossref","first-page":"L550","DOI":"10.1152\/ajplung.00248.2014","article-title":"Oxidized phospholipids protect against lung injury and endothelial barrier dysfunction caused by heat-inactivated Staphylococcus aureus","volume":"308","author":"Meliton","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.bcp.2024.116574_b0195","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-biophys-042910-155359","article-title":"Actin structure and function","volume":"40","author":"Dominguez","year":"2011","journal-title":"Annu Rev Biophys"},{"issue":"10001","key":"10.1016\/j.bcp.2024.116574_b0200","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/S0140-6736(15)60064-2","article-title":"Cerebral fat embolism after bone fractures","volume":"386","author":"Aman","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bcp.2024.116574_b0205","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/15563650.2016.1151528","article-title":"Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration","volume":"54","author":"Hayes","year":"2016","journal-title":"Clin Toxicol (phila)"},{"key":"10.1016\/j.bcp.2024.116574_b0210","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2106\/00004623-196547060-00010","article-title":"Distribution of Fat Tagged with I-131 within the Body of the Rat at Various Times Following Intravenous Injection","volume":"47","author":"Paredes","year":"1965","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"10.1016\/j.bcp.2024.116574_b0215","first-page":"582","article-title":"Pulmonary injury caused by free fatty acid: evaluation of steroid and albumin therapy","volume":"89","author":"Broe","year":"1981","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.bcp.2024.116574_b0220","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00005373-198703000-00015","article-title":"The early biochemical and hormonal profile of patients with long bone fractures at risk of fat embolism syndrome","volume":"27","author":"Schnaid","year":"1987","journal-title":"J Trauma"},{"key":"10.1016\/j.bcp.2024.116574_b0225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-pathol-011110-130158","article-title":"The acute respiratory distress syndrome: pathogenesis and treatment","volume":"6","author":"Matthay","year":"2011","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10.1016\/j.bcp.2024.116574_b0230","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1165\/rcmb.F305","article-title":"Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management","volume":"33","author":"Matthay","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"8","key":"10.1016\/j.bcp.2024.116574_b0235","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI60331","article-title":"The acute respiratory distress syndrome","volume":"122","author":"Matthay","year":"2012","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.bcp.2024.116574_b0240","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/BF02975850","article-title":"Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2)","volume":"27","author":"Joo","year":"2004","journal-title":"Arch Pharm Res"},{"issue":"8","key":"10.1016\/j.bcp.2024.116574_b0245","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/JPER.19-0013","article-title":"Ursodeoxycholic acid attenuates the expression of proinflammatory cytokines in periodontal cells","volume":"91","author":"Talebian","year":"2020","journal-title":"J Periodontol"},{"issue":"12","key":"10.1016\/j.bcp.2024.116574_b0250","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/BF02994760","article-title":"Ursodeoxycholic acid inhibits pro-inflammatory repertoires, IL-1 beta and nitric oxide in rat microglia","volume":"26","author":"Joo","year":"2003","journal-title":"Arch Pharm Res"},{"issue":"7","key":"10.1016\/j.bcp.2024.116574_b0255","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1182\/blood.V91.7.2341","article-title":"Rat neutrophils express alpha4 and beta1 integrins and bind to vascular cell adhesion molecule-1 (VCAM-1) and mucosal addressin cell adhesion molecule-1 (MAdCAM-1)","volume":"91","author":"Davenpeck","year":"1998","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2024.116574_b0260","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4049\/jimmunol.182.1.604","article-title":"Crosstalk between CXCR4\/stromal derived factor-1 and VLA-4\/VCAM-1 pathways regulates neutrophil retention in the bone marrow","volume":"182","author":"Petty","year":"2009","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.bcp.2024.116574_b0265","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.RES.0000013835.53611.97","article-title":"Role of alpha4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium","volume":"90","author":"Bowden","year":"2002","journal-title":"Circ Res"},{"issue":"17","key":"10.1016\/j.bcp.2024.116574_b0270","doi-asserted-by":"crossref","first-page":"9815","DOI":"10.1073\/pnas.96.17.9815","article-title":"Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo","volume":"96","author":"Corada","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.bcp.2024.116574_b0275","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.bmcl.2017.02.045","article-title":"Curcumolide reduces diabetic retinal vascular leukostasis and leakage partly via inhibition of the p38MAPK\/NF-kappa B signaling","volume":"27","author":"Cai","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2024.116574_b0280","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molimm.2020.01.014","article-title":"Dapk1 improves inflammation, oxidative stress and autophagy in LPS-induced acute lung injury via p38MAPK\/NF-kappaB signaling pathway","volume":"120","author":"Li","year":"2020","journal-title":"Mol Immunol"},{"issue":"3","key":"10.1016\/j.bcp.2024.116574_b0285","first-page":"1455","article-title":"GW4064 attenuates lipopolysaccharide-induced hepatic inflammation and apoptosis through inhibition of the Toll-like receptor 4-mediated p38 mitogen-activated protein kinase signaling pathway in mice","volume":"41","author":"Liu","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bcp.2024.116574_b0290","doi-asserted-by":"crossref","unstructured":"C.G. Lee, Y.W. Kim, E.H. Kim, Z. Meng, W. Huang, S.J. Hwang, S.G. Kim, Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1, Gastroenterology 142(5) (2012) 1206-1217 e7.","DOI":"10.1053\/j.gastro.2012.01.007"},{"key":"10.1016\/j.bcp.2024.116574_b0295","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-015-0427-9","article-title":"Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells","volume":"14","author":"He","year":"2015","journal-title":"Mol Cancer"},{"issue":"17","key":"10.1016\/j.bcp.2024.116574_b0300","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1074\/jbc.M109.094524","article-title":"A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition","volume":"285","author":"Lee","year":"2010","journal-title":"J Biol Chem"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224005744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224005744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T03:04:07Z","timestamp":1732849447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224005744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":60,"alternative-id":["S0006295224005744"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116574","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ursodeoxycholic acid alleviates fat embolism syndrome-induced acute lung injury by inhibiting the p38 MAPK\/NF-\u03baB signalling pathway through FXR","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116574"}}